Lv31
260 积分 2025-01-08 加入
Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress
2个月前
已完结
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis
2个月前
已完结
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis
2个月前
已关闭
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis
2个月前
已关闭
Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union
2个月前
已完结
A phase 2 randomized dose-ranging study of the JAK2-selective inhibitor fedratinib (SAR302503) in patients with myelofibrosis
2个月前
已完结
皖公网安备34019202002308
